![Lindsey Rolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lindsey Rolfe
Teknisk/Vetenskaplig/F&U Direktör på
3B Pharmaceuticals GmbH
Förmögenhet: - $ per 2026-08-31
Profil
Lindsey Rolfe is currently an Independent Director at CERo Therapeutics Holdings, Inc. since 2024 and Chief Medical Officer at 3B Pharmaceuticals GmbH since 2023.
Former roles include Independent Director at Atreca, Inc. from 2019 to 2024, Member of The Royal College of Physicians, and Chief Medical Officer & Executive VP-Clinical at Clovis Oncology, Inc. from 2015 to 2023.
Education includes a doctorate from The University of Edinburgh.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
-.--% | 2026-04-28 | 0 ( -.--% ) | - $ | 2026-08-31 |
Aktiva positioner av Lindsey Rolfe
| Företag | Position | Start |
|---|---|---|
3B Pharmaceuticals GmbH
 3B Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops radiopharmaceutical drugs and diagnostics for oncology indications | Teknisk/Vetenskaplig/F&U Direktör | 2023-08-01 |
Tidigare kända positioner av Lindsey Rolfe
| Företag | Position | Slut |
|---|---|---|
| ATRECA, INC. | Direktör/Styrelseledamot | 2024-05-01 |
| CLOVIS ONCOLOGY, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-06-01 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Lindsey Rolfes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
46
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
3B Pharmaceuticals GmbH
3B Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops radiopharmaceutical drugs and diagnostics for oncology indications | Commercial Services |
